Ballerup, Denmark, April 12, 2018 - Today, LEO Pharma A/S, a global leader in medical dermatology and Naked Biome Inc, a San Francisco-based translational microbiome company, announced that LEO Pharma will invest USD 500,000 in Naked Biome. The investment is LEO Pharma`s first in the microbiome area and underpins the company`s dedication to ad-vance science together with partners and develop life-changing medicines, which improve people`s lives. `At LEO Pharma, we innovate to advance science in dermatology and deliver better treatments to people with skin diseases. The microbiome technology shows exciting potential within dermatology, and with our...
|
